Evogene Ltd.EVGNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank8
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P8
Near historical low
vs 2Y Ago
-4.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -64.74% |
| Q2 2025 | 55.60% |
| Q1 2025 | 0.48% |
| Q4 2024 | -5.66% |
| Q3 2024 | 9.66% |
| Q2 2024 | -32.73% |
| Q1 2024 | 27.40% |
| Q4 2023 | -31.14% |
| Q3 2023 | 15.20% |
| Q2 2023 | 18.47% |
| Q1 2023 | -176.65% |
| Q4 2022 | 68.01% |
| Q3 2022 | -5.98% |
| Q2 2022 | 13.61% |
| Q1 2022 | 6.07% |
| Q4 2021 | -41.22% |
| Q3 2021 | 5.30% |
| Q2 2021 | -30.84% |
| Q1 2021 | 31.76% |
| Q4 2020 | -56.44% |
| Q3 2020 | -58.27% |
| Q2 2020 | 49.32% |
| Q1 2020 | -20.14% |
| Q4 2019 | -27.75% |
| Q3 2019 | 8.04% |
| Q2 2019 | 27.58% |
| Q1 2019 | -81.81% |
| Q4 2018 | 26.21% |
| Q3 2018 | -12.38% |
| Q2 2018 | 27.94% |
| Q1 2018 | -38.31% |
| Q4 2017 | -4.70% |
| Q3 2017 | 16.76% |
| Q2 2017 | 15.89% |
| Q1 2017 | -14.96% |
| Q4 2016 | -34.86% |
| Q3 2016 | -38.30% |
| Q2 2016 | -10.47% |
| Q1 2016 | 53.54% |
| Q4 2015 | -69.06% |